Lataa...
Prolonged survival with longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma
BACKGROUND: Though lenalidomide maintenance therapy has demonstrated improved outcomes after autologous hematopoietic stem cell transplantation (auto-HCT) in patients with multiple myeloma (MM), the impact of the duration of this therapy is not clearly known. PATIENTS AND METHODS: We retrospectively...
Tallennettuna:
| Julkaisussa: | Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138119/ https://ncbi.nlm.nih.gov/pubmed/27680710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30366 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|